By leveraging the unique chemical diversity of marine natural products, we seek to discover new lead compounds with the potential to overcome the limitations of current CDK4/6 inhibitors and provide improved therapeutic options for breast cancer patients. The gene discussed is CDK4; the disease is breast carcinoma.